مورد إلكتروني
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) a pragmatic, open-label, non-inferiority, randomised controlled trial
| العنوان: | Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) a pragmatic, open-label, non-inferiority, randomised controlled trial |
|---|---|
| المؤلفون: | Linschoten, Reinier C.A. van, Jansen, F.M., Pauwels, Renske W.M., Smits, Lisa J.T., Atsma, F., Kievit, W., Jong, D.J. de, Jansen, Jeroen, Janneke van der Woude, C., Hoentjen, F. |
| المصدر: | Lancet Gastroenterology & Hepatology; 343; 355; 2468-1253; 4; 8; ~Lancet Gastroenterology & Hepatology~343~355~~~2468-1253~4~8~~ |
| بيانات النشر: | 2023 |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | Item does not contain fulltext |
| URL: | |
| الإتاحة: | Open access content. Open access content |
| أرقام أخرى: | NLQGE oai:repository.ubn.ru.nl:2066/293716 10.1016/S2468-1253(22)00434 1382781825 |
| المصدر المساهم: | RADBOUD UNIVERSITEIT NAJMEGEN From OAIster®, provided by the OCLC Cooperative. |
| رقم الأكسشن: | edsoai.on1382781825 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |